SAN JOSE, Calif., Aug. 14 VNUS(R) MedicalTechnologies, Inc. (Nasdaq: VNUS), a worldwide leader in medical devices forthe minimally invasive treatment of venous reflux disease, is enjoying ...

MINNEAPOLIS, Minnesota – Vascular Solutions, Inc. today announced that it is marketing a reprocessing service for the ClosureFAST radiofrequency ablation catheter in the United States. The ClosureFAST ...

WAYNE, Pa.--(BUSINESS WIRE)--Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies for critical care and surgery, today announced that more than 200,000 ClosureFast ® ...

Study Demonstrates Long-Term Durability of the ClosureFast™ Radiofrequency Ablation System for Treatment of Chronic Venous Insufficiency MANSFIELD, Mass.-- Covidien, a leading global provider of ...

DUBLIN - Feb. 10, 2015 - The ClosureFast(TM) endovenous radiofrequency ablation catheter from Medtronic plc (MDT) is safe and effective for the treatment of chronic venous insufficiency (CVI) over ...

Covidien (Mansfield, Massachusetts) reported the five-year results of its ClosureFast long-term European multi-center study in patients with chronic venous insufficiency (CVI). This study evaluates ...

Covidien Announces Five-Year Results from the ClosureFast™ Long-Term European Multi-Center Study in Patients with Lower Limb Venous Disease Study Demonstrates Long-Term Durability of the ClosureFast™ ...

September 26, 2006 -- The US Food and Drug Administration (FDA) has granted a clinical laboratory improvement amendment waiver for a portable lead test, thereby improving its availability and access, ...

Medical device major Medtronic plc MDT recently unveiled 12-month results from its VeClose study, validating the clinical durability of its VenaSeal closure system, at the European Venous Forum 2015 ...